Clozapine is a well-established anti-psychotic used in the management of treatment-resistant schizophrenia. Despite its efficacy, discontinuation remains a significant clinical concern, yet few studies have systematically examined the factors associated with its cessation. Understanding these correlates is crucial for optimizing patient outcomes and guiding clinical decision-making.
This newly published study provides valuable insights into Clozapine discontinuation patterns and highlights potential management strategies for patients requiring alternative treatment approaches. Read the full article here.
Share this post